Task: Answer the multiple-choice question.
Query: Which drug exhibits a 16.405% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] O=C(Nc1ccc(F)c(F)c1)C1CCN(S(=O)(=O)c2cccc3nonc23)CC1
[b] Cc1cc(C)c(NC(=O)c2cc(=O)c3ccccc3o2)c(C)c1
Answer: a. O=C(Nc1ccc(F)c(F)c1)C1CCN(S(=O)(=O)c2cccc3nonc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Nc1ccc(F)c(F)c1)C1CCN(S(=O)(=O)c2cccc3nonc23)CC1
O=C(Nc1ccc(F)c(F)c1)C1CCN(S(=O)(=O)c2cccc3nonc23)CC1
1-(2,1,3-benzoxadiazol-4-ylsulfonyl)-N-(3,4-difluorophenyl)piperidine-4-carboxamide